12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cialis regulatory update

The European Commission approved a label expansion for 5 mg Cialis tadalafil from Eli Lilly to include the treatment of signs and symptoms of benign prostatic hyperplasia (BPH) in adult males, including those with erectile...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >